Multi-locus stepwise regression: a haplotype-based algorithm for finding genetic associations applied to atopic dermatitis by Knuppel, S. et al.
RESEARCH ARTICLE Open Access
Multi-locus stepwise regression: a haplotype-
based algorithm for finding genetic associations
applied to atopic dermatitis
Sven Knüppel1,7, Jorge Esparza-Gordillo1,2, Ingo Marenholz1,2, Hermann-Georg Holzhütter3, Anja Bauerfeind1,
Andreas Ruether4, Stephan Weidinger5,6, Young-Ae Lee1,2 and Klaus Rohde1*
Abstract
Background: Genome-wide association studies (GWAS) provide an increasing number of single nucleotide
polymorphisms (SNPs) associated with diseases. Our aim is to exploit those closely spaced SNPs in candidate
regions for a deeper analysis of association beyond single SNP analysis, combining the classical stepwise regression
approach with haplotype analysis to identify risk haplotypes for complex diseases.
Methods: Our proposed multi-locus stepwise regression starts with an evaluation of all pair-wise SNP combinations
and then extends each SNP combination stepwise by one SNP from the region, carrying out haplotype regression
in each step. The best associated haplotype patterns are kept for the next step and must be corrected for multiple
testing at the end. These haplotypes should also be replicated in an independent data set. We applied the method
to a region of 259 SNPs from the epidermal differentiation complex (EDC) on chromosome 1q21 of a German
GWAS using a case control set (1,914 individuals) and to 268 families with at least two affected children as
replication.
Results: A 4-SNP haplotype pattern with high statistical significance in the case control set (p = 4.13 × 10-7 after
Bonferroni correction) could be identified which remained significant in the family set after Bonferroni correction
(p = 0.0398). Further analysis revealed that this pattern reflects mainly the effect of the well-known FLG gene;
however, a FLG-independent haplotype in case control set (OR = 1.71, 95% CI: 1.32-2.23, p = 5.6 × 10-5) and family
set (OR = 1.68, 95% CI: 1.18-2.38, p = 2.19 × 10-3) could be found in addition.
Conclusion: Our approach is a useful tool for finding allele combinations associated with diseases beyond single
SNP analysis in chromosomal candidate regions.
Background
Single marker association analysis has been widely used to
identify genetic risk factors involved in the genetics of
complex diseases [1]. Previous studies have suggested that
haplotypes, a collection of ordered markers along a chro-
mosome, may be more appropriate as a unit for statistical
analysis than single genetic markers [2,3]. As demon-
strated by simulation studies, statistical approaches based
on haplotypes can be a powerful method to characterize
the genetic background of complex diseases [1,4-6].
However, since haplotypes are often not directly observa-
ble we have to use unphased genotypes to estimate
haplotypes.
The advent of the gene chip technology has resulted in a
multitude of genome-wide association studies (GWAS).
These are in general based upon large numbers of single
nucleotide polymorphisms (SNPs) genotyped along the
genome for large numbers of individuals. Due to the mul-
titude of tests along the genome, only substantial single
locus associations withstand the Bonferroni correction.
Another possibility to exploit these high quality data of
closely spaced SNPs is to concentrate on certain candidate
regions and use these closely spaced SNPs for haplotype
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estimation. Thus, a more thorough association analysis of
genetic traits can be performed.
Using haplotypes instead of single SNPs, one has to
deal with a much higher number of haplotypes than sin-
gle SNPs in a candidate region. This is because k single
SNPs may give rise to 2k-1 different SNP combinations.
To overcome this issue we used stepwise regression to
find (suboptimal) haplotype patterns from unphased
multi-locus SNP genotype data.
Statistical methods using a given set of unphased geno-
type data to test haplotype effects in the framework of
general linear models have already been proposed [2,3].
We combined these methods with the strategy of classical
stepwise variable selection [7]. The aim of our multi-locus
stepwise regression (MSR) was to find the best haplotype
patterns associated with disease phenotypes.
Stepwise regression based on a limited number of SNPs
to detect haplotype effects has been proposed for indepen-
dent individuals [8-10] as well as for family data [11].
Some methods store in each step all haplotypes below a
certain p value for extension [8,9] or select the optimal
number of SNPs to combine them in a two-step approach
using cross-validation [10]. In order to deal with a larger
number of SNPs in candidate regions given for instance in
the case of GWAS data, our method aims at the extension
and outcome of a preset number of best haplotypes by
using a different search strategy for case-control or family
data, respectively, which have to be corrected for multiple
testing and should be confirmed in an independent data
set.
As proof of principle we applied our method to find
haplotype patterns with effects on atopic dermatitis. As
input, we utilized SNPs from the epidermal differentiation
complex (EDC) located in a 1.9 Mb region on chromo-
some 1q21; these SNPs had been genotyped in 939 cases
and 975 controls as part of a recently performed German
genome-wide association study on atopic dermatitis. Find-
ings were replicated in an independent data set of 268
complete nuclear families with at least two affected sib-
lings affected by atopic dermatitis.
We chose the EDC region for this analysis, because it
contains a lot of candidate genes for atopic dermatitis
encoding structural proteins that are expressed during
terminal differentiation of the human epidermis [12].
Moreover, the EDC contains the filaggrin gene (FLG),
mutations in which are well-known atopic dermatitis sus-
ceptibility factors [12-15]. Linkage [16] and single marker
association results [12] indicate that there may exist addi-
tional susceptibility factors beyond the known FLG muta-
tions in the EDC.
Methods
According to our case control and family data we used
two different routines for the haplotype estimation and
testing part of the multi-locus stepwise regression
(MSR). Haplotypes and their frequencies were inferred
by the expectation-maximization (EM) algorithm in the
case control set [17] and by a modified EM algorithm
for nuclear families [18,19].
Missing genotypes were inferred while estimating hap-
lotypes for every individual before statistical analysis.
Every haplotype association test was based on the same
number of individuals; however, the number of esti-
mated haplotypes may differ between the tests.
Multi-locus stepwise regression (MSR)
All possible SNP pairs are tested separately by haplotype
regression using a global test statistic. Details of the haplo-
type regression are described below. Next, the results were
sorted by global p value and the first nt haplotype patterns
were selected, where nt is the number of stored test results
for further processing in the next step. These haplotype
patterns are called “best” haplotype patterns.
As next step the remaining SNPs from the whole region
were added one by one to the “best” haplotype patterns
and again subjected to haplotype regression. The results
were then sorted by p value and the first nt haplotype pat-
terns were selected. This step was repeated until no more
SNPs could be added or having achieved a preset maxi-
mum number of SNPs, or a stop criterion has been met.
Independent individuals
In case of independent individuals haplotypes were esti-
mated using an expectation- maximization (EM) algo-
rithm [17]. To account for the uncertainty of the
haplotype pair configuration, we weighted each haplotype
pair, compatible with the genotype of an individual, by its
estimated probability and applied haplotype logistic
regression to the binary phenotype [17]. As global test
statistic for haplotype patterns, which we used as regres-
sion model in the MSR, we applied the Likelihood ratio
test, comparing the full model depending on all estimated
individual haplotype probabilities with the reduced model
including only the intercept. To consider further vari-
ables like sex and age the Likelihood ratio test could be
extended by adding the additional variables to the full
and reduced model. The most frequent haplotype was
chosen as baseline. Haplotypes with an estimated fre-
quency of less than 5% were declared as “rare”, and were
pooled. If all estimated haplotypes were “rare” no regres-
sion model was applicable and we skipped this haplotype
pattern. To avoid singularity, quasi-complete and com-
plete separation due to low frequent haplotypes, which is
a sparse data problem and makes the regression model
impracticable, we skipped the pooled rare haplotype if its
frequency was less than 5%. In this case the overall p
value has to be interpreted relative to the baseline and
the excluded rare haplotypes.
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Nuclear families
In order to estimate haplotypes for nuclear families we
used a modification of the EM algorithm for independent
parents, taking into account only those haplotype pair
configurations, which are compatible with the children
[18,19]. For each haplotype pair configuration with its
probability, the respective haplotype pair configuration of
the children and the maternal or paternal origin of the
haplotypes were inferred. The estimated haplotypes were
considered as alleles of a multi-locus marker, and the
TDT statistic for each haplotype pair configuration of a
nuclear family was then calculated according to [20], tak-
ing into account its weight, as given by the product of the
estimated frequencies of the respective haplotypes in the
parents.
Real data example: Application to atopic dermatitis
Atopic dermatitis is a chronic inflammatory skin disease
with complex etiology, which is assumed to be influenced
by multiple genetic as well as environmental factors. Gene
effects on the epidermal differentiation complex (EDC) on
chromosome 1q21 have already been found [21,22]. How-
ever, the roles of all genes and their combination in this
region are not fully understood. The present study
searches for significant haplotype patterns in the EDC
region including 259 high-quality SNPs (Chromosome 1:
150,075,690-152,014,240 bp). We selected 94 tagSNPs
covering all 259 SNPs by a linkage disequilibrium (LD) cri-
terion r2 > 0.8, this way suppressing uninformative SNPs
in high LD. The haplotype estimation via EM algorithm
does not require LD between loci under consideration,
which could not be expected from the tagSNPs. In this
sense an estimated haplotype is a combination of alleles at
their loci, not necessarily in LD. However, since all loci lie
in a restricted region on a chromosome, each individual
carries at its chromosomes a pair of such combinations
with its probability. This forms then a pair of physically
extended haplotypes over the region as basis for multi-
locus stepwise regression.
The discovery and replication data sets included in this
study correspond to data sets 1 and 2, respectively, pre-
viously reported in a German genome-wide association
study [12]. The discovery set included 939 unrelated
German individuals with atopic dermatitis and 975
German controls. The replication data set consisted of 268
complete nuclear families comprising 1,097 individuals
and 529 children with atopic dermatitis. In both study
groups, the physican’s diagnosis of atopic dermatitis was
made according to standard criteria. More details of study
design are described elsewhere [12].
We applied the MSR to the discovery set as long as
the decrease of the arithmetic mean of the ten best p
values’ decadic logarithm in each step was greater 10
percent, as empirical stop criterion. The best 300 haplo-
type patterns derived by MSR in the case control set
were tested in the replication family set. The results of
the weighted TDT statistic were Bonferroni corrected by
multiplying the TDT p value by 300 (the number of pat-
terns from the discovery set tested in the family data).
The crucial step of the analysis is the identification of
the best haplotype patterns in the discovery set. These
best patterns are the result of a search strategy over the
total number of patterns possible and represent only a
suboptimal solution. They may be corrected, however,
for search strategy and multiple testing, taking the total
number of possible of patterns (
m∑
i=1
(
n
i
)
with n as num-
ber of SNPs in the region and m as the number of loci
included in selected best patterns) as Bonferroni
correction.
The analysis was carried out using the statistical soft-
ware R (version 2.11.1) [23]. To identify tagSNPs we
used Tagger [24] implemented in Haploview 4.2 [25].
Information on SNP location was taken from the data-
base SNPselector (NCBI assembly 36, dbSNP build 126)
[26]. All p values lower than 0.05 were considered as
statistically significant.
Results
A total of 1,914 individuals (939 individuals with atopic
dermatitis and 975 controls) and 268 nuclear families
(536 parents and 529 affected children) were included in
the present study. The selected 259 high-quality autoso-
mal SNPs from the epidermal differentiation complex
(EDC) are located on chromosome 1q21 (150,075,690-
152,014,240 kb). We identified 94 tagSNPs using a link-
age disequilibrium (LD) criterion r2 > 0.8 for compres-
sing the genotype information, avoiding haplotype
patterns containing the same information through high
LD, and minimizing computational time.
Running the MSR over the 94 tagSNPs in the discovery
set adding one SNP at a time to the interim best haplotype
patterns led to a decrease of p values. The mean of the
best ten p values decreased from 6.5 × 10-7 (2 loci) over
3.07 × 10-13 (4 loci) to 1.04 × 10-13 (5 loci). The results of
the 10 best SNP patterns in each step of the MSR can be
found in Additional File 1, Table S1. All haplotype pat-
terns in all steps came out with a nominal p value lower
than 0.001. The change of the mean value of the best ten
-log10(p values) decreased from 56% for step from 2 to 3
loci to 4% for step 4 to 5 loci. Stopping at a percentage
change lower than 10% meant that we stopped MSR at
patterns of 4 SNPs.
Result of the MSR search over the discovery set is a list
of 300 best 4-SNP haplotype patterns with nominal p
values in a range from 3.74 × 10-14 to 1.19 × 10-9. It is to
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be noticed that all of these withstand the Bonferroni cor-
rection (
4∑
i=1
(
94
i
)
= 3188010 possible patterns).
To replicate our findings the 300 best 4-SNP haplo-
type patterns derived by MSR in the discovery set were
subsequently tested for association in the family set
(Table 1). After Bonferroni correction of the p values of
the TDT-statistic, one haplotype pattern showed a cor-
rected p value with 0.03976 (nominal 0.00013), lower
than the arbitrary significance threshold of 0.05. This
best replicated haplotype pattern contained the SNPs
rs7550106 (HRNR), rs499697 (LCE3C), rs17659389
(LCE3C), and rs17670505 (LCE1C).
Since longer range LD with filaggrin (FLG) mutations
has been previously described in the EDC region and,
especially, SNP rs7550106 of the best haplotype pattern
is in the same haplotype block as FLG gene, we tried to
find out whether the haplotype association derived was
due to an underlying association with the four known
FLG gene mutations 2282del4, R501X, R2447X, and
S3247X. In order to analyze this in more detail, we
removed all individuals carrying any of these FLG muta-
tions from the data sets and tested whether the best
haplotype pattern still revealed significant association. In
the FLG reduced set, after exclusion of 309 individuals
(240 cases and 69 controls) from the case control set
and 106 families from the family set, the global p values
were still significant and changed from 1.30 × 10-13 (full
case control set) to 0.00015 (FLG reduced case control
set) and from 0.00013 (full family set) to 0.0151 (FLG
reduced family set), indicating an effect additional to the
four FLG mutations.
Another way to evaluate the FLG mutation effects is
the analysis of 8-SNP haplotypes, which were built inde-
pendent of the physical position, by the four SNPs of
the best haplotype pattern in front followed by the four
FLG mutation loci (Table 2). An LD plot of the physi-
cally ordered SNPs can be found in Additional File 1,
Figure S1. We analyzed the 8-SNP haplotypes in the
complete and the FLG reduced data sets, separately. In
order to study low-frequent haplotypes due to the low
frequencies of the FLG mutations we had to keep haplo-
types with a frequency down to 0.001, instead of the
generally used 0.05. The minor SNP allele was coded as
1 and the major one as 2.
Here we are interested in the substructure of the best
pattern, the effect of each of the 8-SNP haplotypes.
Therefore, each of these haplotypes has been tested
separately using the logistic regression in the case con-
trol set resulting in per haplotype odds ratios and their
approximative 95% confidence intervals (95% CI). In the
family set the odds ratios were calculated by the
weighted number of transmitted haplotypes divided by
the weighted number of non-transmitted haplotypes; the
corresponding 95% CIs were calculated by the exact
McNemar test using the nearest integer number of the
weighted number of transmitted and non-transmitted
haplotypes [27]. Though p values and 95% CIs are only
nominal, the odds ratios reflect strength and direction
of haplotype effects in the substructure of our best
pattern.
The most frequent best pattern haplotype 2222 had in
the full set a total frequency of 0.3841 in cases, 0.4166
in controls, and 0.4042 in the families. This haplotype
had been split into 8-SNP haplotypes according to the
FLG mutations. Since the FLG mutations are rare, the
most frequent haplotype (2222-2222) contains no FLG
mutations. The odds ratio (OR = 0.83; 95% CI: 0.72-
0.96; p = 0.0105) of that haplotype was slightly signifi-
cant in the full set and changed toward the null (OR =
1.07; 95% CI: 0.92-1.24; p = 0.410) losing significance, if
all FLG carriers were excluded. This most frequent
Table 1 Resulting ten best haplotype patterns after replication of the multi-locus stepwise regression.
No. SNP 1 SNP 2 SNP 3 SNP 4 MSR
p value
MSR
p value
(corrected)
TDT
p value
TDT
p value
(corrected)
1 rs7550106 rs499697 rs17659389 rs17670505 1.30 × 10-13 4.13 × 10-7 0.00013 0.03976
2 rs499697 rs17670505 rs576941 rs16835086 2.99 × 10-10 9.54 × 10-4 0.00033 0.09809
3 rs13373771 rs499697 rs6702463 rs17670505 9.85 × 10-10 3.14 × 10-3 0.00034 0.10260
4 rs6678672 rs4845766 rs499697 rs17659389 9.70 × 10-10 3.10 × 10-3 0.00040 0.11999
5 rs6678672 rs4845766 rs13373771 rs17659389 1.05 × 10-09 3.34 × 10-3 0.00051 0.15153
6 rs7550106 rs499697 rs989834 rs17670505 4.20 × 10-10 1.34 × 10-3 0.00053 0.15796
7 rs11204897 rs13373771 rs6701221 rs17670505 2.51 × 10-10 8.01 × 10-4 0.00055 0.16504
8 rs499697 rs17659389 rs17670505 rs16835086 4.77 × 10-10 1.52 × 10-3 0.00058 0.17369
9 rs2999547 rs499697 rs17659389 rs17670505 1.65 × 10-10 5.25 × 10-4 0.00061 0.18254
10 rs13373771 rs1923508 rs6701221 rs17670505 7.36 × 10-10 2.35 × 10-3 0.00074 0.22309
Multi-locus stepwise regression (MSR p value) was used for case control set (n = 1,914) and replicated in family set (268 families) using the weighted TDT
statistic. Bonferroni corrections were done by multiplying 3188010 to the MSR p value and 300 to the TDT p value. Only the first haplotype pattern kept
significant after Bonferroni correction.
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haplotype is protective, outbalancing the rare mutation
effects of the FLG loci, e.g. the odds ratio of haplotype
2222-2212 was 4.92 (95% CI: 1.44-16.79; p = 0.00267)
with a frequency of 0.0102 in cases and 0.0035 in
controls.
As seen for best pattern haplotype 2222, the outbalan-
cing protective effect of all best haplotypes patterns carry-
ing no FLG mutation (xxxx-2222) is a general feature of
the significant results of Table 2 caused by the opposite
FLG mutation effects. An exception is the best pattern
haplotype 1222 which showed a risk effect of the non-FLG
haplotype (1222-2222).
Of further interest were the best pattern haplotypes
2122, 2121, 2112, and 1222, which allowed getting deeper
insight into the combination of these haplotypes with
FLG mutations. We found that single FLG mutations in
combination with one of the best pattern haplotypes
showed strong effects with high significance, as can be
seen for 1222-1222 (Case control set: OR = 8.05; 95% CI:
1.51-42.85; p = 0.0028), 2122-2122 (Case control set: OR
= 22.62; 95% CI: 4.17-122.73; p = 7.16 × 10-7; Family set:
OR = 1.67; 95% CI: 0.68-4.32; p = 0.22), 2121-2212 (Case
control set: OR = 31.26; 95% CI: 11.17-87.46; p = 3.10 ×
10-24; Family set: OR = 1.95; 95% CI: 1.40-2.96; p =
0.00066), 2122-2221 (Case control set: OR = 12.65; 95%
CI: 4.54-35.22; p = 1.75 × 10-10; Family set: OR = 1.92;
95% CI: 1.07-3.64; p = 0.0207). As expected, these effects
turn to the null in the FLG reduced data sets, this way
underlying a strong FLG effect reflected by the best pat-
tern. The relatively large confidence intervals of the odds
Table 2 8-SNP haplotype association tests for the best haplotype pattern (rs7550106, rs499697, rs17659389,
rs17670505) derived by multi-locus stepwise regression (MSR) with four known FLG mutations (S3247X, R2447X,
2282del4, R501X) added in that order for case control set and replicated by family set.
Case control set Family set
Freq. (n = 1914) FLG (n = 1914) NON-FLG (n = 1605) FLG (268 families) NON-FLG (162 families)
Haplotypes Cases Controls OR p value OR p value Freq. T:U OR p value T:U OR p value
2222 2222 0.3656 0.4028 0.83 1.05 E-02 1.07 4.10E-01 0.3992 206.3:256.1 0.81 2.08 E-02 138.6:152.4 0.91 4.18 E-01
2222 2212 0.0102 0.0035 4.92 2.67 E-03 0.0039 2.0:6.0 0.33 1.58 E-01
2222 2221 0.0052 0.0062 0.80 6.50 E-01 0.0011 2.1:0.1 38.89 1.66 E-01
2222 2122 0.0030 0.0041 0.63 4.80 E-01 NA NA NA NA
2222 Total 0.3841 0.4166 0.85 2.43 E-02 0.4042 210.4:262.1 0.80 1.74 E-02
2212 2222 0.1180 0.1392 0.78 2.43 E-02 0.95 6.34E-01 0.1077 110.6:91.8 1.20 1.86 E-01 66.5:59.6 1.11 5.42 E-01
2212 2212 0.0014 0.0018 0.53 6.35 E-01 NA NA NA NA
2212 2221 0.0010 0.0012 0.63 7.79 E-01 0.0011 1.1:1.1 1.00 1.00 E+00
2212 Total 0.1204 0.1422 0.76 1.28 E-02 0.1088 111.7:92.9 1.20 1.89 E-01
2122 2222 0.1289 0.1488 0.81 4.78 E-02 0.90 3.44E-01 0.1205 93.7:126.6 0.74 2.66 E-02 64.1:79.9 0.80 1.87 E-01
2122 2221 0.0241 0.0032 12.65 1.75 E-10 0.0267 35.2:18.3 1.92 2.07 E-02
2122 2212 0.0123 0.0037 7.00 1.21 E-04 0.0068 7.0:8.0 0.87 7.91 E-01
2122 2122 0.0114 0.0012 22.62 7.16 E-07 0.0115 15.0:9.0 1.67 2.21 E-01
2122 2211 0.0034 0.0000 NA NA NA NA NA NA
2122 Total 0.1800 0.1569 1.23 2.69 E-02 0.1655 150.9:161.9 0.93 5.34 E-01
2121 2212 0.0448 0.0028 31.26 3.10 E-24 0.0538 74.0:38.0 1.95 6.61 E-04
2121 2222 0.0267 0.0295 0.88 5.63 E-01 0.97 8.94E-01 0.0123 11.8:13.8 0.85 6.92 E-01 5.7:9.7 0.59 3.08 E-01
2121 2221 0.0075 0.0000 NA NA 0.0019 2.0:2.0 1.00 1.00 E+00
2121 Total 0.0790 0.0322 2.65 5.22 E-10 0.0680 87.7:53.7 1.63 4.22 E-03
2112 2222 0.0562 0.0892 0.49 2.43 E-06 0.59 8.22E-04 0.0582 46.8:68.0 0.69 4.73 E-02 24.2:36.3 0.67 1.19 E-01
2112 2212 0.0041 0.0016 6.23 4.20 E-02 0.0048 4.0:6.0 0.67 5.27 E-01
2112 2221 0.0015 0.0010 2.59 4.73 E-01 0.0029 2.1:3.0 0.69 6.75 E-01
2112 Total 0.0618 0.0917 0.60 3.89 E-04 0.0659 52.8:77.1 0.69 3.37 E-02
1222 2222 0.0982 0.0785 1.36 1.69 E-02 1.71 5.55E-05 0.1186 124.8:88.6 1.41 1.30 E-02 92.0:54.9 1.68 2.19 E-03
1222 1222 0.0061 0.0010 8.05 2.77 E-03 NA NA NA NA
1222 Total 0.1043 0.0795 1.42 4.81 E-03 0.1186 124.8:88.6 1.41 1.30 E-02
Logistic regression was used for testing a single haplotype for the case control set and the weighted TDT statistic was used for a single haplotype by computing
transmitted (T) versus non-transmitted (U) haplotypes. Calculations were carried out for the full set (FLG) and the FLG reduced sets (NON-FLG). The minor allele
was coded as 1 and the major one as 2. For the sake of following the rare FLG mutations the frequency threshold for the 8-SNP haplotype estimation had been
lowered to 0.001, however, only combined with best pattern haplotypes down to a total frequency > 0.05 in the full case set.
Abbreviations are as follows: Freq., haplotype frequency; OR, odds ratio; FLG, Filaggrin gene; T:U, transmitted:non-transmitted; NA, not available.
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ratios in the case control set are due to the low haplotype
frequencies.
Most of the haplotype effects could be explained by the
four known FLG mutations but not all. For haplotype
1222-2222, already mentioned, with a frequency of 0.0982
in cases, 0.0785 in controls, and 0.1186 in families, con-
taining only the risk allele of SNP rs7550106 and the
major alleles of the other SNPs, we found an increase in
significance and odds ratio on single haplotype basis, indi-
cating an additional effect to the four known FLG muta-
tions. It showed an increase in the odds ratio for that
single haplotype from 1.36 (95% CI: 1.06-1.74; p = 0.0169)
to 1.71 (95% CI: 1.32-2.23; p = 0.000056) in case control
set and from 1.41 (95% CI: 1.06-1.86; p = 0.013) to 1.68
(95% CI: 1.18-2.38; p = 0.00219) in family set after exclu-
sion of individuals carrying one or more FLG mutations.
This indicates an additional FLG independent effect on
atopic dermatitis.
Discussion
A multi-locus stepwise regression (MSR) strategy has been
developed to identify haplotype patterns or at least multi-
locus allelic combinations with genetic effects from
unphased multi-locus genotype data on phenotype. The
MSR was applied to 94 tagSNPs out of 259 SNPs from the
epidermal differentiation complex (EDC) on chromosome
1q21 with genotype data from a German genome-wide
association study to find genetic markers associated with
atopic dermatitis. We could successfully apply our method
to the identification of the well-known filaggrin (FLG)
mutations (2282del4, R501X, R2447X, and S3247X) and
we could show an effect additional to these.
Our method focussed on forward selection due to the
high number of SNPs included, which made a backward
selection starting with the full number of SNPs impractic-
able. Thus we started with pairwise haplotypes and kept in
every step the most significant 300 ones for the extension
by one SNP (nt = 300). This restriction, to follow only 300
best patterns, is owed to computational feasibility and
leads to a mere suboptimal solution. We may miss a pat-
tern which fails to reach the best 300 patterns in an earlier
step and may reach the top in later steps. To evaluate the
effect of the pre-defined number of stored tests in each
step (nt) we varied nt to 50, 100, and 500. For all of these
selection strategies we obtained the same result for the
best patterns due to the fact that our best patterns showed
a strong effect in the case control set. In smaller samples
or samples with a weaker genetic effect the variation of nt
could have an influence on the final selected patterns.
The stepwise algorithm stops if a further extension of
the pattern by one SNP does not lead to an essential
increase in significance. We used as empirical stop criter-
ion a decrease of the best ten -log10(p values) mean by
less than 10%. Our stop criterion differs from those more
elaborated ones in hapConstructor [8] and SHARE [10]. It
has been chosen with the aim to estimate the general
effect of stepwise added SNPs in a simple manner. Even in
the unlikely case that only one of the 10 best patterns
would increase by one order of magnitude and the other
nine were not changed, the search would not stop. The
saturation effect of our criterion with increasing numbers
of SNPs for our data is presented in Additional File 1, Fig-
ure S2. However, for other data sets saturation may come
up for different SNP numbers. Since the best patterns for
each step are given out in an ordered list as shown in
Additional File 1, Table S1, we recommend checking
those lists carefully for patterns down to only two SNPs
with a higher significance than the patterns in the last step.
Two other parameters influence the search: the maxi-
mum number of SNPs in the patterns (maxSNP) and
the number of patterns kept in each step (nt). The max-
imum number of SNPs limits the maximum length the
search pattern should have. Clearly, this should be larger
than the onset of the saturation effect. If this is not the
case, maxSNP should be set higher. On the other hand
if maxSNP allows longer patterns the frequencies of
estimated haplotypes will get smaller and smaller mak-
ing a reliable statistics problematic. The number of SNP
patterns kept in each step (nt) influences the sensitivity
of our method. The larger nt, the deeper the search, and
the better the chance to not overlook a true positive
result. On the other hand, large nt values need more
memory and computing time, so that one has to find a
trade-off between sensitivity and feasibility for each data
set. To simulate this process and to give an advice for
setting the parameters is a difficult task and we must
admit that in the light of our straightforward approach
we have refrained from simulations and power
calculations.
It should be clear, that p values of patterns found by
MSR in a discovery set are inflated by the search process
and may give only a locus pattern which (sub)-optimally
differentiates between affected and unaffected indivi-
duals. Unlike hapConstructor [8] and SHARE [10] which
determine the significance of the best pattern from only
one data set via permutation tests, we rely on an inde-
pendent data set for replication. Without such a replica-
tion set we had to carry out the lengthy procedure of
permutation testing as well, or if possible, use the maxi-
mum of different patterns as “conservative” Bonferroni
correction not taking into account the prior probability
of the candidate region.
The restriction to use the tagSNPs of the region had a
twofold effect. It reduced the required computing time
by reducing the number of loci and haplotype patterns
to analyze, and it avoided similar patterns, which differ
only in loci with high LD, to be stored in the list of the
best 300 pattern for the next step.
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The best haplotype pattern found in the discovery set
and replicated in an independent set of nuclear families
consists of SNPs from hornerin (HRNR) and the late corni-
fied envelope (LCE) gene cluster in the epidermal differen-
tiation complex (EDC). These genes are involved in skin
barrier function. Statistical significance of the pattern does
not necessarily mean a functional effect of all its SNP on
atopic dermatitis; it could be sufficient that the inclusion
of the SNP information of those genes provides only a
proper background for analyzing the atopic dermatitis
effects best.
Using this background we tried to answer the question,
whether the mutation of SNP rs7550106 located in the
FLG block is a pure reflection of the known FLG effect
[13]. We have two indications that there is an additional
effect. Removal of all individuals carrying at least one of
the known FLG mutations kept the found pattern signifi-
cant in both data sets. Extending the best pattern found by
the known FLG mutations, and analyzing the resulting 8-
SNP haplotypes in the full set, led to highly significant
haplotypes carrying a FLG mutation. In addition, a signifi-
cant haplotype carrying none of these mutations could be
found, whose effect came then out much stronger in the
FLG reduced data sets. This finding is in line with the
indication of residual linkage in the EDC region after
accounting for two FLG mutations (R501X and 2282del4),
made by [14], but is much more distinct with respect to
the underlying haplotype structure.
Several studies have proposed stepwise regression based
on haplotypes [8-11]. Like these our method assesses the
effect of stepwise enlarged haplotypes on phenotypes of
interest, applying a different search strategy for a larger
number of SNPs. These approaches are a powerful tool by
excluding uninformative SNPs and concentrating on the
informative ones for distinction between affected and
unaffected individuals, thus leading to more concise
interpretations.
While the MSR worked well for our study, its function
can be easily extended to other types of analysis, e.g. survi-
val data of a cohort study. It can be applied to other phe-
notypes, such as continuous or categorical phenotypes.
Conclusions
To conclude, the MSR is an effective approach to identify
subsets of SNPs the haplotypes of which are significantly
associated with a phenotype. The MSR keeps the advan-
tages of stepwise regression models and haplotype statis-
tical analysis. The MSR was, as proof of principle,
successfully applied to the case control and family sets of
atopic dermatitis patients and yielded one, significantly
replicated, haplotype pattern including SNPs from HRNR
and the LCE gene cluster. It was shown that haplotype
effects independent of the four known FLG mutations
could be detected; however, we cannot exclude a yet
unknown FLG mutation beyond those four FLG muta-
tions. Further replication through additional studies, fine
mapping and functional studies will be required to gain
better understanding of etiological determinants underly-
ing this allergic disorder. The MSR provides an in-depth
analysis of the influence of SNP combinations on pheno-
types beyond single SNP analyses.
Additional material
Additional file 1: Table S1. 10 best SNP patterns in each step of the
Multi-locus stepwise regression (MSR) based on case control set (n
= 1914). The results of the global test statistic (Likelihood ratio p value)
and model criteria (Nagelkerke R2, AIC, and BIC) of the haplotype logistic
regression models of the best 10 SNP patterns in each step are shown.
Figure S1. LD plot of the four SNPs of the best 4-SNP pattern and the
four FLG mutations based on the case control set. An LD plot
(Haploview 4.2) shows on the basis of D’ the LD-structure of the best 4-
SNP pattern formed together with the known four FLG mutations in
physical locus order. Figure S2. Mean of -log10(p values) of best 10 p
values in each step of the Multi-locus stepwise regression based on case
control sample. This figure shows the saturation effect of decrease of the
mean of the ten best transformed p values with increasing pattern
length.
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